Tilray Brands (TLRY) Stock: Why It's Up Today
Updated Oct 20, 2026, 12:04 PM ET · intraday price
- Trading at $3.06 as of 12:04 PM ET, +0.99% vs the prior close of $3.03.
- Volume 1.09M shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TLRY rises 1.0% to $3.06. Trading at $3.06 (intraday, 12:04 PM ET), +0.99% vs the prior close of $3.03. Day range $3.01–$3.07, opened at $3.03.
TLRY daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — TLRY rises 1.0% to $3.06
- Trading at $3.06 (intraday, 12:04 PM ET), +0.99% vs the prior close of $3.03. Day range $3.01–$3.07, opened at $3.03.
- Volume was 1.09M shares, 0.3x its 50-day average of 3.87M — lighter than usual.
- Price is -25.3% vs its 50-day average ($4.10) and -46.6% vs its 200-day average ($5.73).
- 52-week range $3.00–$16.20; the current price sits at 0% of that range, 81.1% below the 52-week high.
Oct 19, 2026 — TLRY dips 0.3% to $3.03, a 52-week low
- Closed at $3.03, -0.33% vs the prior close of $3.04. Day range $3.00–$3.07, opened at $3.06.
- Volume was 2.53M shares, 0.7x its 50-day average of 3.89M.
- Price is -26.5% vs its 50-day average ($4.12) and -47.5% vs its 200-day average ($5.77).
- 52-week range $3.00–$16.20; today's close sits at 0% of that range, 81.3% below the 52-week high.
Oct 16, 2026 — TLRY slides 5.3% to $3.04, a 52-week low
- Closed at $3.04, -5.30% vs the prior close of $3.21. Day range $3.03–$3.26, opened at $3.25.
- Volume was 2.93M shares, 0.7x its 50-day average of 3.90M.
- Price is -26.8% vs its 50-day average ($4.15) and -47.6% vs its 200-day average ($5.80).
- 52-week range $3.03–$16.90; today's close sits at 0% of that range, 82.0% below the 52-week high.
Oct 15, 2026 — TLRY rises 2.2% to $3.21
- Closed at $3.21, +2.23% vs the prior close of $3.14. Day range $3.07–$3.28, opened at $3.09.
- Volume was 2.65M shares, 0.7x its 50-day average of 3.94M.
- Price is -23.2% vs its 50-day average ($4.18) and -44.9% vs its 200-day average ($5.83).
- 52-week range $3.07–$18.40; today's close sits at 1% of that range, 82.6% below the 52-week high.
Oct 14, 2026 — TLRY slides 4.0% to $3.14, a 52-week low, 6 down days in a row
- Closed at $3.14, -3.98% vs the prior close of $3.27. Day range $3.10–$3.29, opened at $3.24.
- Volume was 4.67M shares, 1.2x its 50-day average of 3.98M.
- Price is -25.3% vs its 50-day average ($4.21) and -46.4% vs its 200-day average ($5.86).
- 52-week range $3.10–$18.40; today's close sits at 0% of that range, 82.9% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — TLRY dips 2.7% to $3.27, a 52-week low, 5 down days in a row
- Closed at $3.27, -2.68% vs the prior close of $3.36. Day range $3.25–$3.39, opened at $3.31.
- Volume was 4.10M shares, 1.0x its 50-day average of 4.02M.
- Price is -22.8% vs its 50-day average ($4.24) and -44.5% vs its 200-day average ($5.89).
- 52-week range $3.25–$18.40; today's close sits at 0% of that range, 82.2% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — TLRY slides 5.1% to $3.36, a 52-week low, 4 down days in a row
- Closed at $3.36, -5.08% vs the prior close of $3.54. Day range $3.34–$3.56, opened at $3.56.
- Volume was 3.88M shares, 1.0x its 50-day average of 4.07M.
- Price is -21.2% vs its 50-day average ($4.26) and -43.3% vs its 200-day average ($5.92).
- 52-week range $3.34–$20.20; today's close sits at 0% of that range, 83.4% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — TLRY dips 1.4% to $3.54, a 52-week low, 3 down days in a row
- Closed at $3.54, -1.39% vs the prior close of $3.59. Day range $3.39–$3.63, opened at $3.60.
- Volume was 5.73M shares, 1.4x its 50-day average of 4.11M.
- Price is -17.4% vs its 50-day average ($4.29) and -40.6% vs its 200-day average ($5.96).
- 52-week range $3.38–$23.20; today's close sits at 1% of that range, 84.7% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — TLRY slides 3.5% to $3.59 on 2.2x normal volume
- Closed at $3.59, -3.49% vs the prior close of $3.72. Day range $3.38–$3.67, opened at $3.49.
- Volume was 9.30M shares, 2.2x its 50-day average of 4.17M — unusually heavy trading.
- Price is -16.5% vs its 50-day average ($4.30) and -40.1% vs its 200-day average ($5.99).
- 52-week range $3.38–$23.20; today's close sits at 1% of that range, 84.5% below the 52-week high.
- SEC filings that day: 10-Q, 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 7, 2026 — TLRY dips 1.6% to $3.72
- Closed at $3.72, -1.59% vs the prior close of $3.78. Day range $3.70–$3.76, opened at $3.75.
- Volume was 3.37M shares, 0.8x its 50-day average of 4.21M.
- Price is -13.7% vs its 50-day average ($4.31) and -38.3% vs its 200-day average ($6.03).
- 52-week range $3.54–$23.20; today's close sits at 1% of that range, 84.0% below the 52-week high.
Oct 6, 2026 — TLRY rises 1.6% to $3.78, 3 up days in a row
- Closed at $3.78, +1.61% vs the prior close of $3.72. Day range $3.70–$3.84, opened at $3.74.
- Volume was 3.63M shares, 0.9x its 50-day average of 4.21M.
- Price is -12.4% vs its 50-day average ($4.31) and -37.8% vs its 200-day average ($6.08).
- 52-week range $3.54–$23.20; today's close sits at 1% of that range, 83.7% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — TLRY jumps 3.0% to $3.72
- Closed at $3.72, +3.05% vs the prior close of $3.61. Day range $3.61–$3.79, opened at $3.65.
- Volume was 4.36M shares, 1.0x its 50-day average of 4.25M.
- Price is -13.9% vs its 50-day average ($4.32) and -39.2% vs its 200-day average ($6.12).
- 52-week range $3.54–$23.20; today's close sits at 1% of that range, 84.0% below the 52-week high.
Oct 2, 2026 — TLRY rises 1.1% to $3.61
- Closed at $3.61, +1.12% vs the prior close of $3.57. Day range $3.55–$3.65, opened at $3.61.
- Volume was 4.12M shares, 1.0x its 50-day average of 4.25M.
- Price is -16.5% vs its 50-day average ($4.32) and -41.5% vs its 200-day average ($6.17).
- 52-week range $3.54–$23.20; today's close sits at 0% of that range, 84.4% below the 52-week high.
TLRY bull case vs bear case (from the data)
- Annual revenue grew 11.5% in the latest fiscal year (SEC XBRL).
- Insiders made 12 open-market purchases in the last 12 months.
- Share count down 86.8% in a year (buybacks).
- Price is -25.3% vs its 50-day average — short-term trend is down.
- Price is -46.6% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $121.40M.
TLRY latest news & SEC filings
Every SEC filing by or about TLRY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Revenue: $257.15M (prior year $209.50M) (+22.7% vs Aug 31, 2025)
- Net income: -$43.14M (prior year -$322.00K) (loss widened vs Aug 31, 2025)
- Diluted EPS: -$0.32 (prior year $0.00)
Oct 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 28, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Sep 28, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 28, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 18, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gendel Mitchell bought 2,500 shares at $4.43 (≈$11.07K) on Aug 6, 2026
- Gendel Mitchell bought 2,500 shares at $4.43 (≈$11.07K) on Aug 6, 2026
- Gendel Mitchell bought 2,500 shares at $4.43 (≈$11.07K) on Aug 6, 2026
- Gendel Mitchell bought 2,500 shares at $4.43 (≈$11.07K) on Aug 6, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Merton Carl A bought 10,000 shares at $4.62 (≈$46.20K) on Aug 4, 2026
- Merton Carl A bought 10,000 shares at $4.62 (≈$46.20K) on Aug 4, 2026
- Merton Carl A bought 10,000 shares at $4.62 (≈$46.20K) on Aug 4, 2026
- Merton Carl A bought 10,000 shares at $4.62 (≈$46.20K) on Aug 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 31, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade TLRY
- Last results release: Oct 8, 2026 (8-K Item 2.02). Previous ones: Jul 28, 2026, Apr 1, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Jan 7, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.62% (largest 5.3%).
- Liquidity: about 4.09M shares (≈$12.50M) trade per day on average.
- 52-week position: $3.06 vs a range of $3.00–$16.20 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Dec 2, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 4 sales; latest: Mitchell Gendel bought 2,500 shares on Aug 6, 2026.
- Latest filings: 10-Q Oct 8, 2026; 8-K Oct 8, 2026; 8-K Sep 14, 2026.
- Share count: 147.79M shares outstanding (Oct 6, 2026), -86.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
TLRY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 3.03 | 3.07 | 3.01 | 3.06 | 1.09M |
| Oct 19, 2026 | 3.05 | 3.07 | 3.00 | 3.03 | 2.55M |
| Oct 16, 2026 | 3.25 | 3.26 | 3.03 | 3.04 | 3.04M |
| Oct 15, 2026 | 3.09 | 3.28 | 3.07 | 3.21 | 2.67M |
| Oct 14, 2026 | 3.24 | 3.29 | 3.10 | 3.14 | 4.67M |
| Oct 13, 2026 | 3.31 | 3.39 | 3.25 | 3.27 | 4.10M |
| Oct 12, 2026 | 3.56 | 3.56 | 3.34 | 3.36 | 3.88M |
| Oct 9, 2026 | 3.60 | 3.63 | 3.39 | 3.54 | 5.73M |
| Oct 8, 2026 | 3.49 | 3.67 | 3.38 | 3.59 | 9.30M |
| Oct 7, 2026 | 3.75 | 3.76 | 3.70 | 3.72 | 3.37M |
| Oct 6, 2026 | 3.74 | 3.84 | 3.70 | 3.78 | 3.63M |
| Oct 5, 2026 | 3.65 | 3.79 | 3.61 | 3.72 | 4.36M |
| Oct 2, 2026 | 3.61 | 3.65 | 3.55 | 3.61 | 4.12M |
| Oct 1, 2026 | 3.77 | 3.77 | 3.54 | 3.57 | 7.03M |
| Sep 30, 2026 | 3.96 | 3.97 | 3.68 | 3.75 | 7.53M |
| Sep 29, 2026 | 4.03 | 4.06 | 3.94 | 3.95 | 3.50M |
| Sep 28, 2026 | 4.07 | 4.10 | 3.98 | 4.02 | 3.79M |
| Sep 25, 2026 | 4.11 | 4.16 | 4.03 | 4.13 | 2.14M |
| Sep 24, 2026 | 4.09 | 4.14 | 4.05 | 4.07 | 2.37M |
| Sep 23, 2026 | 4.21 | 4.24 | 4.11 | 4.11 | 2.85M |
About Tilray Brands
Tilray Brands (TLRY) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in NEW YORK, NY. Fiscal year ends May 31. SEC CIK 1731348.
TLRY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David F Clanachan | Director | Jul 30, 2026 |
| Steven Michael Cohen | Director | Jul 30, 2026 |
| Johann Michael Herhalt | Director | Jul 30, 2026 |
| David G. Hopkinson | Director | Jul 30, 2026 |
| Thomas P. Looney | Director | Jul 30, 2026 |
| Renah Persofsky | Director | Jul 30, 2026 |
| Irwin D Simon | President and CEO | Aug 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Denise M Faltischek | Chief Strategy Officer | Aug 27, 2026 |
| Mitchell Gendel | Global General Counsel | Aug 27, 2026 |
| Carl A Merton | Chief Financial Officer | Aug 27, 2026 |
| Irwin D Simon | President and CEO | Aug 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 6, 2026 | Mitchell Gendel | Buy | 2,500 | $4.43 |
| Aug 6, 2026 | Mitchell Gendel | Buy | 2,500 | $4.43 |
| Aug 6, 2026 | Mitchell Gendel | Buy | 2,500 | $4.43 |
| Aug 6, 2026 | Mitchell Gendel | Buy | 2,500 | $4.43 |
| Aug 4, 2026 | Carl A Merton | Buy | 10,000 | $4.62 |
| Aug 4, 2026 | Carl A Merton | Buy | 10,000 | $4.62 |
| Aug 4, 2026 | Carl A Merton | Buy | 10,000 | $4.62 |
| Aug 4, 2026 | Carl A Merton | Buy | 10,000 | $4.62 |
| Aug 3, 2026 | Denise M Faltischek | Buy | 2,500 | $4.78 |
| Aug 3, 2026 | Denise M Faltischek | Buy | 2,500 | $4.78 |
| Aug 3, 2026 | Denise M Faltischek | Buy | 2,500 | $4.78 |
| Aug 3, 2026 | Denise M Faltischek | Buy | 2,500 | $4.78 |
| Apr 21, 2026 | David G. Hopkinson | Sale | 33,556 | $6.94 |
| Apr 21, 2026 | David G. Hopkinson | Sale | 33,556 | $6.94 |
| Apr 21, 2026 | David G. Hopkinson | Sale | 33,556 | $6.94 |
TLRY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| May 31, 2026 | $915.45M | $-121.40M | -1.09 | $-69.14M |
| May 31, 2025 | $821.31M | $-2.19B | -24.56 | $-94.60M |
| May 31, 2024 | $788.94M | $-244.98M | -3.30 | $-30.91M |
| May 31, 2023 | $627.12M | $-1.45B | -2.35 | $7.91M |
| May 31, 2022 | $628.37M | $-476.80M | -0.99 | $-177.26M |
Latest balance sheet: total assets $2.33B, total liabilities $721.28M, cash $214.96M (as of Aug 31, 2026).
TLRY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 8, 2026 | 8-K Item 2.02 (results) | $3.59 |
| Jul 28, 2026 | 8-K Item 2.02 (results) | $4.03 |
| Apr 1, 2026 | 8-K Item 2.02 (results) | $6.14 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $9.13 |
| Oct 9, 2025 | 8-K Item 2.02 (results) | $21.00 |
| Jul 28, 2025 | 8-K Item 2.02 (results) | $7.00 |
| Apr 8, 2025 | 8-K Item 2.02 (results) | $4.60 |
| Jan 10, 2025 | 8-K Item 2.02 (results) | $12.30 |
| Oct 10, 2024 | 8-K Item 2.02 (results) | — |
| Jul 29, 2024 | 8-K Item 2.02 (results) | — |
| Apr 9, 2024 | 8-K Item 2.02 (results) | — |
| Jan 9, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Glass House Brands (GLAS)IM Cannabis (IMCC)Aurora Cannabis (ACB)Regencell Bioscience (RGC)Cronos (CRON)Usana Health Sciences (USNA)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on TLRY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 12:04 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.